ORTX - Orchard Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.25B
Enterprise Value 3953.96M
Trailing P/E N/A
Forward P/E 1-10.32
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)602.04
Price/Book (mrq)4.35
Enterprise Value/Revenue 3459.52
Enterprise Value/EBITDA 6-3.84

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-12,023.89%

Management Effectiveness

Return on Assets (ttm)-65.01%
Return on Equity (ttm)-131.55%

Income Statement

Revenue (ttm)2.08M
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)1.65M
EBITDA -248.18M
Net Income Avi to Common (ttm)-245.92M
Diluted EPS (ttm)-5.88
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)295.41M
Total Cash Per Share (mrq)3.44
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.18
Book Value Per Share (mrq)3.35

Cash Flow Statement

Operating Cash Flow (ttm)-126.95M
Levered Free Cash Flow (ttm)N/A

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3∞%
S&P500 52-Week Change 34.25%
52 Week High 321.64
52 Week Low 38.65
50-Day Moving Average 317.91
200-Day Moving Average 316.19

Share Statistics

Avg Vol (3 month) 3189.59k
Avg Vol (10 day) 3204.67k
Shares Outstanding 511.79M
Float 62.22M
% Held by Insiders 10.00%
% Held by Institutions 158.40%
Shares Short (May 31, 2019) 42.56M
Short Ratio (May 31, 2019) 415.64
Short % of Float (May 31, 2019) 4N/A
Short % of Shares Outstanding (May 31, 2019) 42.97%
Shares Short (prior month Apr 30, 2019) 41.86M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A